mRNA |
QS11 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.004 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
neratinib |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
silmitasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.004 |
mRNA |
AR-42 |
GDSC1000 |
pan-cancer |
AAC |
0.088 |
0.005 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.005 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
0.095 |
0.006 |
mRNA |
CEP-701 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.007 |
mRNA |
Bortezomib |
CTRPv2 |
pan-cancer |
AAC |
-0.093 |
0.007 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.097 |
0.008 |